Camilla de Almeida Martins

COVID‐19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE‐IBD registry

A. Hino, R. Ungaro, P. Kotze, 2021, Journal of gastroenterology and hepatology.

Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey

A. Hino, R. Saad-Hossne, M. Motta, 2021, World journal of gastroenterology.

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases

N. Queiroz, K. Garcia, C. Martins, 2022, Frontiers in Medicine.

Practical Aspects of Proactive TDM for Anti-TNF Agents in IBD: Defining Time Points and Thresholds to Target

A. Moss, N. Queiroz, C. Sobrado, 2019, Crohn's & Colitis 360.

IBD barriers across the continents: a continent-specific analysis: Latin America

P. Kotze, A. Quaresma, N. Queiroz, 2023, Therapeutic advances in gastroenterology.